Free Trial
→ Trump’s national nightmare is here (From Porter & Company) (Ad)tc pixel Free CCAP Stock Alerts

Crescent Capital BDC (CCAP) Financials

Crescent Capital BDC logo
$15.81 -0.01 (-0.06%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$15.81 0.00 (0.00%)
As of 09/12/2025 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Crescent Capital BDC

Annual Income Statements for Crescent Capital BDC

This table shows Crescent Capital BDC's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 84 -43 0.26 -16
Consolidated Net Income / (Loss)		 79 -43 0.26 -16
Net Income / (Loss) Continuing Operations		 79 -43 0.26 -16
Total Pre-Tax Income 		79 -43 0.26 -16
Total Revenue		 83 0.00 0.00 0.00
Net Interest Income / (Expense)		 83 0.00 0.00 0.00
Total Interest Income		 83 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00 0.00
Total Non-Interest Income		 0.79 0.00 0.00 0.00
Net Realized & Unrealized Capital Gains on Investments		 - 0.00 0.00 0.00
Total Non-Interest Expense		 4.40 0.00 0.00 0.00
Nonoperating Income / (Expense), net		 - -43 0.26 -16
Basic Earnings per Share		 $1.67 $1.93 $2.30 $2.40
Weighted Average Basic Shares Outstanding		 28.48M 30.89M 35.93M 37.06M
Diluted Earnings per Share		 $1.67 $1.93 $2.30 $2.40
Weighted Average Diluted Shares Outstanding		 28.48M 30.89M 35.93M 37.06M
Weighted Average Basic & Diluted Shares Outstanding		 - 30.89M 37.06M 37.06M

Quarterly Income Statements for Crescent Capital BDC

This table shows Crescent Capital BDC's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -18 -23 -9.93 1.41 0.98 7.80 4.35 -1.50 -1.77 -17
Consolidated Net Income / (Loss)		 -18 -23 -9.93 1.41 0.98 7.80 4.35 -1.50 -1.77 -17
Net Income / (Loss) Continuing Operations		 -18 -23 -9.93 1.41 0.98 7.80 4.35 -1.50 -1.77 -17
Total Pre-Tax Income 		-18 -22 -9.93 1.41 0.98 7.80 4.35 -1.50 -1.77 -17
Total Revenue		 0.00 -19 0.00 0.00 0.00 - 0.00 0.00 6.44 -6.44
Total Non-Interest Income		 0.00 -25 0.00 0.00 0.00 - 0.00 0.00 6.44 -6.44
Net Realized & Unrealized Capital Gains on Investments		 0.00 -25 0.00 0.00 0.00 - 0.00 0.00 6.44 -6.44
Nonoperating Income / (Expense), net		 -18 - -9.93 1.41 0.98 7.80 4.35 -1.50 -8.22 -10
Basic Earnings per Share		 $0.52 $0.52 $0.54 $0.56 $0.59 $0.61 $0.63 $0.59 $0.64 $0.54
Weighted Average Basic Shares Outstanding		 30.89M 30.89M 32.47M 37.06M 37.06M 35.93M 37.06M 37.06M 37.06M 37.06M
Diluted Earnings per Share		 $0.52 $0.52 $0.54 $0.56 $0.59 $0.61 $0.63 $0.59 $0.64 $0.54
Weighted Average Diluted Shares Outstanding		 30.89M 30.89M 32.47M 37.06M 37.06M 35.93M 37.06M 37.06M 37.06M 37.06M
Weighted Average Basic & Diluted Shares Outstanding		 30.89M 30.89M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M

Annual Cash Flow Statements for Crescent Capital BDC

This table details how cash moves in and out of Crescent Capital BDC's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 8.68 -6.46 7.40 15
Net Cash From Operating Activities		 -158 28 92 59
Net Cash From Continuing Operating Activities		 -158 28 92 59
Net Income / (Loss) Continuing Operations		 84 16 84 74
Consolidated Net Income / (Loss)		 84 16 84 74
Amortization Expense		 -8.73 -5.12 -5.17 -6.46
Non-Cash Adjustments to Reconcile Net Income		 -227 8.55 13 -10
Changes in Operating Assets and Liabilities, net		 -5.35 8.97 0.66 2.04
Net Cash From Investing Activities		 0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities		 0.00 0.00 0.00 0.00
Net Cash From Financing Activities		 166 -34 -85 -43
Net Cash From Continuing Financing Activities		 166 -34 -85 -43
Issuance of Debt		 790 339 548 347
Issuance of Common Equity		 53 0.00 0.00 0.00
Repayment of Debt		 -629 -318 -565 -312
Repurchase of Common Equity		 -0.52 0.00 0.00 0.00
Payment of Dividends		 -48 -55 -65 -75
Other Financing Activities, Net		 0.54 -0.22 -3.86 -3.43
Effect of Exchange Rate Changes		 0.01 -0.01 0.09 -0.49
Cash Interest Paid		 15 27 55 60
Cash Income Taxes Paid		 2.18 1.97 0.67 1.34

Quarterly Cash Flow Statements for Crescent Capital BDC

This table details how cash moves in and out of Crescent Capital BDC's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 2.60 -4.39 17 -13 1.29 1.72 7.48 4.19 1.70 1.59
Net Cash From Operating Activities		 -18 42 16 20 21 35 39 -25 47 -2.89
Net Cash From Continuing Operating Activities		 -17 41 16 20 21 35 39 -25 47 -2.89
Net Income / (Loss) Continuing Operations		 -2.38 2.60 7.78 23 23 31 28 20 15 9.99
Consolidated Net Income / (Loss)		 -2.38 2.60 7.78 23 23 31 28 20 15 9.99
Amortization Expense		 -0.89 -0.95 -1.38 -0.80 -1.22 -1.76 -1.79 -1.55 -1.82 -1.31
Non-Cash Adjustments to Reconcile Net Income		 -13 38 20 -12 15 -9.29 21 -44 26 -14
Changes in Operating Assets and Liabilities, net		 -1.04 1.29 -9.91 11 -15 15 -7.36 0.04 7.28 2.07
Net Cash From Financing Activities		 21 -47 1.40 -33 -20 -33 -32 29 -45 4.97
Net Cash From Continuing Financing Activities		 21 -47 1.40 -33 -20 -33 -32 29 -45 4.97
Issuance of Debt		 98 62 156 46 233 113 60 125 55 107
Repayment of Debt		 -62 -97 -138 -64 -235 -127 -73 -75 -82 -83
Payment of Dividends		 -14 -13 -13 -15 -18 -19 -19 -19 -19 -18
Other Financing Activities, Net		 - - -3.63 - -0.23 0.01 0.00 -1.90 - -1.53
Effect of Exchange Rate Changes		 -0.01 -0.01 0.00 0.02 -0.03 0.10 -0.07 0.06 0.02 -0.49
Cash Interest Paid		 9.16 7.13 15 12 17 12 18 13 17 13
Cash Income Taxes Paid		 - - 0.53 - - 0.14 1.26 - - 0.08

Annual Balance Sheets for Crescent Capital BDC

This table presents Crescent Capital BDC's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 2,515 1,303 1,627 1,656
Cash and Due from Banks		 - 6.40 7.78 10
Restricted Cash		 - 11 17 29
Trading Account Securities		 - 8.15 1,587 4.82
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00
Other Assets		 2,515 1,268 1.46 1,600
Total Liabilities & Shareholders' Equity		 0.00 1,303 1,627 1,656
Total Liabilities		 0.00 690 885 916
Other Short-Term Payables		 - 5.86 3.45 3.71
Long-Term Debt		 0.00 654 845 876
Other Long-Term Liabilities		 0.00 18 21 21
Commitments & Contingencies		 - 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 0.00 613 743 741
Total Preferred & Common Equity		 0.00 613 743 741
Preferred Stock		 - 0.00 0.00 0.00
Total Common Equity		 0.00 613 743 741
Common Stock		 - 675 966 959
Retained Earnings		 - -62 -223 -218

Quarterly Balance Sheets for Crescent Capital BDC

This table presents Crescent Capital BDC's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024
Total Assets		 1,339 1,631 1,625 1,624 1,620 1,672 1,645
Cash and Due from Banks		 13 21 7.54 6.00 6.74 11 17
Restricted Cash		 9.41 13 14 17 25 25 21
Trading Account Securities		 - 7.51 7.07 8.85 4.71 2.77 1.40
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets		 1,317 23 1,584 28 21 23 1,595
Total Liabilities & Shareholders' Equity		 1,339 1,631 1,625 1,624 1,620 1,672 1,645
Total Liabilities		 717 913 899 894 869 920 896
Other Short-Term Payables		 - - 3.24 - - - 3.76
Long-Term Debt		 691 883 859 864 840 891 857
Other Long-Term Liabilities		 25 30 23 30 29 29 21
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 623 718 726 730 752 752 749
Total Preferred & Common Equity		 623 718 726 730 752 752 749
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 623 718 726 730 752 752 749
Common Stock		 666 788 788 788 966 966 966
Retained Earnings		 -44 -70 -63 -58 -214 -213 -217

Annual Metrics And Ratios for Crescent Capital BDC

This table displays calculated financial ratios and metrics derived from Crescent Capital BDC's official financial filings.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - -
Revenue Growth		 638.18% -100.00% 0.00% 0.00%
EBITDA Growth		 396.17% -107.29% -1.04% -25.05%
EBIT Growth		 496.17% -100.00% 0.00% 0.00%
NOPAT Growth		 -21.30% -100.00% 0.00% 0.00%
Net Income Growth		 44.39% -154.95% 100.61% -6,125.86%
EPS Growth		 -7.22% 15.57% 19.17% 4.35%
Operating Cash Flow Growth		 -155.11% 117.73% 230.21% -36.18%
Free Cash Flow Firm Growth		 0.00% 151.23% -125.67% 90.92%
Invested Capital Growth		 0.00% -49.63% 25.29% 1.83%
Revenue Q/Q Growth		 0.00% 0.00% 100.00% -100.00%
EBITDA Q/Q Growth		 0.00% 0.00% 93.35% -157.96%
EBIT Q/Q Growth		 0.00% 0.00% 100.00% -100.00%
NOPAT Q/Q Growth		 0.00% 0.00% 100.00% -100.00%
Net Income Q/Q Growth		 0.00% 0.00% 100.36% -278.49%
EPS Q/Q Growth		 0.00% 0.00% 4.07% -2.83%
Operating Cash Flow Q/Q Growth		 0.00% 121.89% -7.28% -38.89%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 98.18%
Invested Capital Q/Q Growth		 0.00% 0.00% 6,612,903.38% 0.65%
Profitability Metrics		 - - - -
EBITDA Margin		 84.25% 0.00% 0.00% 0.00%
EBIT Margin		 94.72% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 94.72% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 100.00% 0.00% 0.00% 0.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 6.28% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 6.28% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% -14.16% 0.04% -2.14%
Cash Return on Invested Capital (CROIC)		 -193.72% 66.00% -22.45% -1.82%
Operating Return on Assets (OROA)		 3.14% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 3.14% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 0.00% -14.16% 0.04% -2.14%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -7.08% 0.04% -2.14%
Net Operating Profit after Tax (NOPAT)		 79 0.00 0.00 0.00
NOPAT Margin		 94.72% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 0.00% 2.74% -0.04% 1.84%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 5.28% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 79 0.00 0.00 0.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 70 -5.12 -5.17 -6.46
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.00 0.51 0.78 0.96
Price to Tangible Book Value (P/TBV)		 0.00 0.51 0.78 0.96
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 2,192.89 0.00
Dividend Yield		 13.51% 17.55% 11.63% 10.61%
Earnings Yield		 0.00% 0.00% 0.05% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.75 0.88 0.96
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 34.07 15.14 26.29
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.76 0.00 0.00
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 1.07 1.14 1.18
Long-Term Debt to Equity		 0.00 1.07 1.14 1.18
Financial Leverage		 0.00 5.17 1.11 1.16
Leverage Ratio		 0.00 6.23 2.16 2.21
Compound Leverage Factor		 0.00 0.00 0.00 0.00
Debt to Total Capital		 0.00% 51.65% 53.22% 54.18%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 51.65% 53.22% 54.18%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 48.35% 46.78% 45.82%
Debt to EBITDA		 0.00 -127.92 -163.43 -135.49
Net Debt to EBITDA		 0.00 -124.59 -158.70 -129.40
Long-Term Debt to EBITDA		 0.00 -127.92 -163.43 -135.49
Debt to NOPAT		 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - -
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 -2,436 1,248 -320 -29
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - -
Asset Turnover		 0.03 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - -
Invested Capital		 2,515 1,267 1,587 1,616
Invested Capital Turnover		 0.07 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 2,515 -1,248 320 29
Enterprise Value (EV)		 0.00 952 1,397 1,549
Market Capitalization		 0.00 315 577 712
Book Value per Share		 $0.00 $19.83 $20.04 $19.98
Tangible Book Value per Share		 $0.00 $19.83 $20.04 $19.98
Total Capital		 0.00 1,267 1,587 1,616
Total Debt		 0.00 654 845 876
Total Long-Term Debt		 0.00 654 845 876
Net Debt		 0.00 637 820 836
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 0.00 43 -0.26 16
Net Nonoperating Obligations (NNO)		 2,515 654 845 876
Total Depreciation and Amortization (D&A)		 -8.73 -5.12 -5.17 -6.46
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $0.00 $1.93 $2.30 $2.40
Adjusted Weighted Average Basic Shares Outstanding		 0.00 30.89M 35.93M 37.06M
Adjusted Diluted Earnings per Share		 $0.00 $1.93 $2.30 $2.40
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 30.89M 35.93M 37.06M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 30.89M 37.06M 37.06M
Normalized Net Operating Profit after Tax (NOPAT)		 55 0.00 0.00 0.00
Normalized NOPAT Margin		 66.31% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 94.72% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Payout Ratios		 - - - -
Dividend Payout Ratio		 60.46% -127.45% 24,543.73% -474.73%
Augmented Payout Ratio		 61.12% -127.45% 24,543.73% -474.73%

Quarterly Metrics And Ratios for Crescent Capital BDC

This table displays calculated financial ratios and metrics derived from Crescent Capital BDC's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 -100.00% 0.00% -100.00% 100.00% 100.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 62.29% 0.00% -102.58% 96.05% 93.69% 88.31% -29.19% -93.38% 477.70% -340.34%
EBIT Growth		 100.00% 0.00% -100.00% 100.00% 100.00% 100.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Growth		 100.00% 0.00% -100.00% 100.00% 100.00% 100.00% 0.00% 0.00% 0.00% 0.00%
Net Income Growth		 -544.73% 0.00% -118.15% 107.82% 105.27% 133.41% 143.81% -206.09% -281.85% -316.93%
EPS Growth		 15.56% 0.00% 38.46% 12.00% 13.46% 17.31% 16.67% 5.36% 8.47% -11.48%
Operating Cash Flow Growth		 0.00% 136.78% 43.35% 390.57% 218.22% -17.31% 146.74% -221.14% 119.82% -108.35%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 100.19% 0.00% -5,489,327.66% -23,525,510.03% -6,671,974.99% 89.51%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 25.29% 5,489,227.66% 23,525,610.03% 6,690,663.48% 1.83%
Revenue Q/Q Growth		 100.00% 0.00% 100.00% -100.00% -100.00% 0.00% -100.00% 0.00% 529.82% -200.00%
EBITDA Q/Q Growth		 95.61% -1,591.69% 97.90% 92.92% -300.00% -43.79% -129.59% -160.48% 251.67% -267.64%
EBIT Q/Q Growth		 100.00% 0.00% 100.00% 100.00% -100.00% 0.00% -100.00% -100.00% 529.82% -200.00%
NOPAT Q/Q Growth		 100.00% 0.00% 100.00% 100.00% -100.00% 0.00% -100.00% -100.00% 529.82% -200.00%
Net Income Q/Q Growth		 1.94% -31.72% 84.68% -97.81% -31.00% 700.21% -44.26% 0.00% -18.28% -854.60%
EPS Q/Q Growth		 4.00% 0.00% 3.85% 3.70% 5.36% 3.39% 3.28% 0.00% 8.47% -15.63%
Operating Cash Flow Q/Q Growth		 -158.07% 331.68% -61.75% 27.05% 4.99% 62.06% 14.14% 0.00% 290.52% -106.16%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 99.90% -98.00% -1,334,760.86% -20,467.03% -39,312.72% -144,797.96% 97.90%
Invested Capital Q/Q Growth		 0.00% 0.00% -462.51% 124.09% -111.43% 6,612,903.38% 26,530,182.33% 1,273,864.77% 603,676.02% 0.65%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 71.75% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -27.52% 0.00%
Tax Burden Percent		 100.00% 108.42% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 0.00% 152.73% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -27.52% 262.69%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.58% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.11% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.13% 0.00%
Return on Equity (ROE)		 0.00% -14.16% 0.00% 0.00% 0.00% 0.04% 0.00% 0.00% 1.70% -2.14%
Cash Return on Invested Capital (CROIC)		 0.00% 98.52% 0.00% 0.00% 0.00% -22.45% -99.09% 1.41% -99.45% -1.82%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.20% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.60% 0.00%
Return on Common Equity (ROCE)		 0.00% -14.16% 0.00% 0.00% 0.00% 0.04% 0.00% 0.00% 1.70% -2.14%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.93% 1.55% 1.19% 0.00%
Net Operating Profit after Tax (NOPAT)		 0.00 -15 0.00 0.00 0.00 0.00 0.00 0.00 4.51 -4.51
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 70.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 0.00% 1.26% -68,461.49% -40,454.40% 8,123.44% -1.04% -1.04% 0.34% 1.47% 1.44%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 0.00 -14 0.00 0.00 0.00 0.00 0.00 0.00 6.44 -6.44
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.89 -15 -1.38 -0.80 -1.22 -1.76 -1.79 -1.55 4.62 -7.75
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.51 0.00 0.00 0.00 0.78 0.78 0.00 0.89 0.96
Price to Tangible Book Value (P/TBV)		 0.00 0.51 0.00 0.00 0.00 0.78 0.78 0.00 0.89 0.96
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 2,242.77 0.00 37.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 2,192.89 40.57 0.00 75.30 0.00
Dividend Yield		 15.86% 17.55% 15.54% 13.20% 11.56% 11.63% 12.00% 11.39% 11.36% 10.61%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.05% 2.46% 0.00% 1.33% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.75 0.00 67,909.39 0.00 0.88 0.88 0.00 0.93 0.96
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 5,315.82 0.00 82.34 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 133.41 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 5,315.82 0.00 82.34 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 96.16 0.00 167.58 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 34.07 10.54 7.89 5.54 15.14 12.07 0.00 15.44 26.29
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 1.07 0.00 0.00 0.00 1.14 1.12 1.18 1.14 1.18
Long-Term Debt to Equity		 0.00 1.07 0.00 0.00 0.00 1.14 1.12 1.18 1.14 1.18
Financial Leverage		 0.00 1.07 0.00 0.00 0.00 1.11 1.12 1.18 1.14 1.16
Leverage Ratio		 0.00 6.23 0.00 0.00 0.00 2.16 2.16 2.22 2.20 2.21
Compound Leverage Factor		 0.00 9.52 0.00 0.00 0.00 0.00 0.00 0.00 -0.60 5.82
Debt to Total Capital		 0.00% 51.65% 100.00% 100.00% 100.00% 53.22% 52.78% 54.21% 53.38% 54.18%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 51.65% 100.00% 100.00% 100.00% 53.22% 52.78% 54.21% 53.38% 54.18%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 48.35% 0.00% 0.00% 0.00% 46.78% 47.22% 45.79% 46.62% 45.82%
Debt to EBITDA		 0.00 -127.92 0.00 0.00 0.00 -163.43 -158.22 167.92 76.86 -135.49
Net Debt to EBITDA		 0.00 -124.59 0.00 0.00 0.00 -158.70 -152.21 161.11 73.47 -129.40
Long-Term Debt to EBITDA		 0.00 -127.92 0.00 0.00 0.00 -163.43 -158.22 167.92 76.86 -135.49
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 57.79 76.63 96.55 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 55.59 73.52 92.29 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 57.79 76.63 96.55 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 0.03 -0.01 0.02 -320 -1,592 -1,643 -1,602 -34
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 0.00 1,267 -0.03 0.01 -0.02 1,587 1,592 1,643 1,606 1,616
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.00
Increase / (Decrease) in Invested Capital		 0.00 0.00 -0.03 0.01 -0.02 320 1,592 1,643 1,606 29
Enterprise Value (EV)		 0.00 952 346 474 551 1,397 1,398 0.00 1,488 1,549
Market Capitalization		 0.00 315 346 474 551 577 590 0.00 669 712
Book Value per Share		 $0.00 $19.83 $0.00 $0.00 $0.00 $20.04 $20.28 $20.30 $20.20 $19.98
Tangible Book Value per Share		 $0.00 $19.83 $0.00 $0.00 $0.00 $20.04 $20.28 $20.30 $20.20 $19.98
Total Capital		 0.00 1,267 -0.12 -0.06 -0.06 1,587 1,592 1,643 1,606 1,616
Total Debt		 0.00 654 -0.12 -0.06 -0.06 845 840 891 857 876
Total Long-Term Debt		 0.00 654 -0.12 -0.06 -0.06 845 840 891 857 876
Net Debt		 0.00 637 -0.12 -0.06 -0.06 820 808 855 819 836
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 18 8.28 9.93 -1.41 -0.98 -7.80 -4.35 1.50 6.28 12
Net Nonoperating Obligations (NNO)		 0.00 654 -0.03 0.01 -0.02 845 840 891 857 876
Total Depreciation and Amortization (D&A)		 -0.89 -0.95 -1.38 -0.80 -1.22 -1.76 -1.79 -1.55 -1.82 -1.31
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.52 $0.52 $0.54 $0.56 $0.59 $0.61 $0.63 $0.59 $0.64 $0.54
Adjusted Weighted Average Basic Shares Outstanding		 30.89M 30.89M 32.47M 37.06M 37.06M 35.93M 37.06M 37.06M 37.06M 37.06M
Adjusted Diluted Earnings per Share		 $0.52 $0.52 $0.54 $0.56 $0.59 $0.61 $0.63 $0.59 $0.64 $0.54
Adjusted Weighted Average Diluted Shares Outstanding		 30.89M 30.89M 32.47M 37.06M 37.06M 35.93M 37.06M 37.06M 37.06M 37.06M
Adjusted Basic & Diluted Earnings per Share		 ($0.08) $0.00 $0.24 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 30.89M 30.89M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M
Normalized Net Operating Profit after Tax (NOPAT)		 0.00 -15 0.00 0.00 0.00 0.00 0.00 0.00 4.51 -4.51
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 70.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -27.52% 0.00%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% -127.45% -48.29% -315.91% -81.14% 24,543.73% 486.88% 643.88% 851.51% -474.73%
Augmented Payout Ratio		 0.00% -127.45% -48.29% -315.91% -81.14% 24,543.73% 486.88% 643.88% 851.51% -474.73%

Key Financial Trends

Crescent Capital BDC (NASDAQ:CCAP) has experienced volatile financial performance over the last four years, showing significant swings in net income and capital gains, accompanied by steady debt issuance and repayments. Here’s an overview of key trends and notable points based on the most recent quarterly financials through Q4 2024 and prior periods.

  • The company’s consolidated net income turned positive in the earlier quarters of 2024, with Q1 2024 net income of $28.0 million and Q2 2024 at $20.4 million, showing strong earnings recovery compared to losses in Q1 2023 and before.
  • Operating cash flow is generally robust with net cash from continuing operating activities frequently positive and substantial, e.g., $39.5 million in Q1 2024 and $46.9 million in Q3 2024.
  • Crescent Capital has maintained strong liquidity as reflected in increasing cash & equivalents on the balance sheet from $6.7 million in Q1 2024 to $17.1 million in Q3 2024, bolstered by restricted cash balances exceeding $20 million consistently.
  • The company actively manages its long-term debt, with large issuances offset by significant repayments each quarter, for example, $107.5 million issued and $82.8 million repaid in Q4 2024, indicating active balance sheet management.
  • Despite volatility, equity levels have generally increased over time, with total common equity rising from approximately $622 million in Q3 2022 to $749 million by Q3 2024.
  • No interest income reported in 2023 and 2024, highlighting Crescent Capital’s emphasis on non-interest income sources or possible changes in portfolio structure or accounting presentation.
  • Shares outstanding remained constant at about 37 million, indicating no dilution from equity issuance during the most recent periods analyzed.
  • Notable swings in net realized and unrealized capital gains show volatility in investment valuation. For example, Q4 2024 reported a net loss of about $6.4 million in capital gains, whereas Q3 2024 showed a gain of $6.4 million. This volatility negatively impacts earnings predictability.
  • Q4 2024 reflected a net loss of $16.9 million, a steep decline from prior positive quarters, driven by a $10.5 million net nonoperating expense and negative capital gain adjustments.
  • The company routinely pays sizable dividends, with payments around $18-19 million each quarter, which could pressure cash flow if earnings volatility persists.

Overall, Crescent Capital BDC presents a somewhat volatile earnings profile primarily driven by fluctuations in non-operating income and capital gains on investments. However, the company shows good operational cash flow and active debt management to sustain financial flexibility. Retail investors should be mindful of this volatility, especially the impact of unrealized investment gains and losses on quarterly earnings, while noting solid balance sheet and liquidity management.

09/13/25 03:03 AM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About Crescent Capital BDC's Financials

When does Crescent Capital BDC's fiscal year end?

According to the most recent income statement we have on file, Crescent Capital BDC's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Crescent Capital BDC's net income changed over the last 3 years?

Crescent Capital BDC's net income appears to be on a downward trend, with a most recent value of -$15.85 million in 2024, falling from $78.94 million in 2021. The previous period was $263 thousand in 2023. Find out what analysts predict for Crescent Capital BDC in the coming months.

How has Crescent Capital BDC's revenue changed over the last 3 years?

Over the last 3 years, Crescent Capital BDC's total revenue changed from $83.34 million in 2021 to $0.00 in 2024, a change of -100.0%.

How much debt does Crescent Capital BDC have?

Crescent Capital BDC's total liabilities were at $915.64 million at the end of 2024, a 3.5% increase from 2023, and a 91,563,700,000.0% increase since 2021.

How much cash does Crescent Capital BDC have?

In the past 3 years, Crescent Capital BDC's cash and equivalents has ranged from $0.00 in 2021 to $10.13 million in 2024, and is currently $10.13 million as of their latest financial filing in 2024.

How has Crescent Capital BDC's book value per share changed over the last 3 years?

Over the last 3 years, Crescent Capital BDC's book value per share changed from 0.00 in 2021 to 19.98 in 2024, a change of 1,998.4%.


Related Companies

This page (NASDAQ:CCAP) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners
Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...
Stansberry Research | Sponsoredtc pixel
Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...
Brownstone Research | Sponsoredtc pixel
Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...
Investors Alley | Sponsoredtc pixel
Forget Tesla — This Tiny AI Stock Is Musk’s Real Play
While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...
Behind the Markets | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Nvidia Times 1,000,000
Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...
Paradigm Press | Sponsoredtc pixel
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...
InvestorPlace | Sponsoredtc pixel
October 16 Changes the Microchip Game — and Investing
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...
Banyan Hill Publishing | Sponsoredtc pixel